147 related articles for article (PubMed ID: 36317836)
1. Dextromethorphan: From Cough Suppressant to Antidepressant.
Kverno K
J Psychosoc Nurs Ment Health Serv; 2022 Nov; 60(11):9-11. PubMed ID: 36317836
[TBL] [Abstract][Full Text] [Related]
2. Classics in Chemical Neuroscience: Dextromethorphan (DXM).
McClure EW; Daniels RN
ACS Chem Neurosci; 2023 Jun; 14(12):2256-2270. PubMed ID: 37290117
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan/Bupropion: First Approval.
Keam SJ
CNS Drugs; 2022 Nov; 36(11):1229-1238. PubMed ID: 36301443
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials.
Majeed A; Xiong J; Teopiz KM; Ng J; Ho R; Rosenblat JD; Phan L; Cao B; McIntyre RS
Expert Opin Emerg Drugs; 2021 Mar; 26(1):63-74. PubMed ID: 33682569
[TBL] [Abstract][Full Text] [Related]
5. The antitussive effect of dextromethorphan in relation to CYP2D6 activity.
Abdul Manap R; Wright CE; Gregory A; Rostami-Hodjegan A; Meller ST; Kelm GR; Lennard MS; Tucker GT; Morice AH
Br J Clin Pharmacol; 1999 Sep; 48(3):382-7. PubMed ID: 10510150
[TBL] [Abstract][Full Text] [Related]
6. Cough Suppressant and Fluoxetine in the Treatment of Pseudobulbar Affect: A Case Report.
Butler MI; Williams D; Cotter DR
J Clin Psychopharmacol; 2016 Oct; 36(5):525-6. PubMed ID: 27496344
[No Abstract] [Full Text] [Related]
7. Dextromethorphan is an effective cough suppressant.
Lexchin J
J Emerg Med; 2001 May; 20(4):415-6. PubMed ID: 11394377
[No Abstract] [Full Text] [Related]
8. Chondroprotective Effects and Mechanisms of Dextromethorphan: Repurposing Antitussive Medication for Osteoarthritis Treatment.
Chen LW; Liu FC; Hung LF; Huang CY; Lien SB; Lin LC; Lai JH; Ho LJ
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534535
[TBL] [Abstract][Full Text] [Related]
9. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
Patatanian E; Casselman J
Consult Pharm; 2014 Apr; 29(4):264-9. PubMed ID: 24704895
[TBL] [Abstract][Full Text] [Related]
11. Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule.
Lauterbach EC
Psychopharmacol Bull; 2016 Aug; 46(2):53-58. PubMed ID: 27738380
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan/quinidine (Nuedexta) for pseudobulbar affect.
Med Lett Drugs Ther; 2011 Jun; 53(1366):46-7. PubMed ID: 21659969
[No Abstract] [Full Text] [Related]
13. Dextromethorphan-induced mania.
Polles A; Griffith JL
Psychosomatics; 1996; 37(1):71-4. PubMed ID: 8600498
[No Abstract] [Full Text] [Related]
14. Use of Compounded Dextromethorphan-Quinidine Suspension for Pseudobulbar Affect in Hospice Patients.
Wahler RG; Reiman AT; Schrader JV
J Palliat Med; 2017 Mar; 20(3):294-297. PubMed ID: 27997281
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pseudobulbar affect in ALS: October 26 highlight and commentary.
Hingorani VN; Kittrelle JP
Neurology; 2005 May; 64(10):1821; author reply 1821. PubMed ID: 15911831
[No Abstract] [Full Text] [Related]
16. Dextromethorphan inhibits activations and functions in dendritic cells.
Chen DY; Song PS; Hong JS; Chu CL; Pan IH; Chen YM; Lin CH; Lin SH; Lin CC
Clin Dev Immunol; 2013; 2013():125643. PubMed ID: 23781253
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan-induced manic symptoms in a bipolar patient on lithium.
Bostwick JM
Psychosomatics; 1996; 37(6):571-3. PubMed ID: 8942208
[No Abstract] [Full Text] [Related]
18. Current concepts in the pharmacotherapy of pseudobulbar affect.
Pioro EP
Drugs; 2011 Jun; 71(9):1193-207. PubMed ID: 21711063
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
Saavedra JS; Garrett PI; Honeycutt SC; Peterson AM; White JW; Hillhouse TM
Pharmacol Biochem Behav; 2020 Oct; 197():173003. PubMed ID: 32755625
[TBL] [Abstract][Full Text] [Related]
20. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders.
Nguyen L; Thomas KL; Lucke-Wold BP; Cavendish JZ; Crowe MS; Matsumoto RR
Pharmacol Ther; 2016 Mar; 159():1-22. PubMed ID: 26826604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
